CAS 45533-87-7

(2-methyl-1H-imidazol-5-yl)methanol

Description:

(2-Methyl-1H-imidazol-5-yl)methanol, with the CAS number 45533-87-7, is an organic compound characterized by its imidazole ring structure, which is a five-membered heterocyclic compound containing two nitrogen atoms. This substance features a hydroxymethyl group (-CH2OH) attached to the imidazole ring, specifically at the 5-position, and a methyl group (-CH3) at the 2-position. The presence of these functional groups contributes to its potential as a versatile building block in organic synthesis and medicinal chemistry. The compound is likely to exhibit polar characteristics due to the hydroxymethyl group, which can engage in hydrogen bonding, influencing its solubility in polar solvents. Additionally, the imidazole moiety may impart biological activity, making it of interest in pharmaceutical applications. Its stability and reactivity can be influenced by the electronic effects of the nitrogen atoms in the ring, which can participate in various chemical reactions. Overall, (2-methyl-1H-imidazol-5-yl)methanol is a compound of interest for its structural features and potential applications in various fields of chemistry.

Formula: C₅H₈N₂O

InChI: InChI=1/C5H8N2O/c1-4-6-2-5(3-8)7-4/h2,8H,3H2,1H3,(H,6,7)

SMILES: Cc1ncc(CO)[nH]1

Synonyms:

• (2-Methyl-1H-imidazol-4-yl)methanol
• 1H-imidazole-4-methanol, 2-methyl-
• 1H-imidazole-5-methanol, 2-methyl-

(2-Methyl-1H-imidazol-4-yl)methanol

CAS: 45533-87-7

Formula: C₅H₈N₂O

Color and Shape: Solid

Molecular weight: 112.1298

Ref: IN-DA00DCOJ

4-(Hydroxymethyl)-2-methyl-1H-imidazole

CAS: 45533-87-7

4-(Hydroxymethyl)-2-methyl-1H-imidazole

Formula: C₅H₈N₂O

Purity: ≥95%

Color and Shape: faint yellow/orange crystalline solid

Molecular weight: 112.13g/mol

Ref: 54-OR3686

4-(Hydroxymethyl)-2-methyl-1H-imidazole

CAS: 45533-87-7

4-(Hydroxymethyl)-2-methyl-1H-imidazole (HMI) is a diamine that has been shown to inhibit translation in mouse fibroblast cells. HMI is used for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease, and it has also been shown to have haemodynamic effects. The clinical relevance of HMI is not well understood, but it has been found to be an effective anti-inflammatory agent in animal models. The drug is administered orally or by injection.

Purity: Min. 95%

Ref: 3D-VBA53387